Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices

E. J. Neufeld, L. Solimeno, D. Quon, C. Walsh, S. Seremetis, D. Cooper, N. N. Iyer, C. S. Hoxer, P. Giangrande

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: While there is substantial literature addressing the principles of general management of haemophilia, literature on perioperative management of haemostasis is scarce. Objective: The aim of this study was to better understand perioperative management among congenital haemophilia B patients (without inhibitors) and to gain insights into real-world surgical practices. Method: A systematic literature review, with an emphasis on haemophilia B, was conducted using EMBASE®, Medline® and the Cochrane Library. Studies from 1974 to June 2015 were accessed, and 132 studies were eligible for the full-study review. An international expert panel with five haematologists and one surgeon reviewed the resulting literature and provided further insights. Results: The literature review revealed that documented experience in the perioperative management of bleeding risk in haemophilia B patients is relatively scarce. Therefore, the review was amended to provide a comprehensive overview of the perioperative management for haemophilia A and B patients; the expert panel applied a particular focus to haemophilia B. Several gaps were identified in the literature including the lack of consensus on defining surgery in terms of bleeding risk, optimal factor levels during surgery and lack of robust evidence on surgical outcomes. The ensuing discussions with the expert panel provided validation of some of the results from the systematic literature review and proposed future directions for perioperative management. Suggestions included collaboration with haemophilia treatment centres (HTCs) to collect real-world data on perioperative management, establishing the need for optimal factor level monitoring practice, and the appropriate adoption of extended half-life products in clinical settings.

Original languageEnglish
Pages (from-to)821-831
JournalHaemophilia
Volume23
Issue number6
DOIs
Publication statusPublished - 2017

Fingerprint

Hemophilia B
Hemophilia A
Hemorrhage
Risk Management
Hemostasis
Libraries
Half-Life

Keywords

  • Expert panel
  • Guideline
  • Haemophilia B
  • Literature review
  • Replacement therapy
  • Surgery

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)

Cite this

Neufeld, E. J., Solimeno, L., Quon, D., Walsh, C., Seremetis, S., Cooper, D., ... Giangrande, P. (2017). Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices. Haemophilia, 23(6), 821-831. https://doi.org/10.1111/hae.13279

Perioperative management of haemophilia B : A critical appraisal of the evidence and current practices. / Neufeld, E. J.; Solimeno, L.; Quon, D.; Walsh, C.; Seremetis, S.; Cooper, D.; Iyer, N. N.; Hoxer, C. S.; Giangrande, P.

In: Haemophilia, Vol. 23, No. 6, 2017, p. 821-831.

Research output: Contribution to journalArticle

Neufeld, EJ, Solimeno, L, Quon, D, Walsh, C, Seremetis, S, Cooper, D, Iyer, NN, Hoxer, CS & Giangrande, P 2017, 'Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices', Haemophilia, vol. 23, no. 6, pp. 821-831. https://doi.org/10.1111/hae.13279
Neufeld, E. J. ; Solimeno, L. ; Quon, D. ; Walsh, C. ; Seremetis, S. ; Cooper, D. ; Iyer, N. N. ; Hoxer, C. S. ; Giangrande, P. / Perioperative management of haemophilia B : A critical appraisal of the evidence and current practices. In: Haemophilia. 2017 ; Vol. 23, No. 6. pp. 821-831.
@article{1c559cec32a84927a716a0c0ac7a1d54,
title = "Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices",
abstract = "Background: While there is substantial literature addressing the principles of general management of haemophilia, literature on perioperative management of haemostasis is scarce. Objective: The aim of this study was to better understand perioperative management among congenital haemophilia B patients (without inhibitors) and to gain insights into real-world surgical practices. Method: A systematic literature review, with an emphasis on haemophilia B, was conducted using EMBASE{\circledR}, Medline{\circledR} and the Cochrane Library. Studies from 1974 to June 2015 were accessed, and 132 studies were eligible for the full-study review. An international expert panel with five haematologists and one surgeon reviewed the resulting literature and provided further insights. Results: The literature review revealed that documented experience in the perioperative management of bleeding risk in haemophilia B patients is relatively scarce. Therefore, the review was amended to provide a comprehensive overview of the perioperative management for haemophilia A and B patients; the expert panel applied a particular focus to haemophilia B. Several gaps were identified in the literature including the lack of consensus on defining surgery in terms of bleeding risk, optimal factor levels during surgery and lack of robust evidence on surgical outcomes. The ensuing discussions with the expert panel provided validation of some of the results from the systematic literature review and proposed future directions for perioperative management. Suggestions included collaboration with haemophilia treatment centres (HTCs) to collect real-world data on perioperative management, establishing the need for optimal factor level monitoring practice, and the appropriate adoption of extended half-life products in clinical settings.",
keywords = "Expert panel, Guideline, Haemophilia B, Literature review, Replacement therapy, Surgery",
author = "Neufeld, {E. J.} and L. Solimeno and D. Quon and C. Walsh and S. Seremetis and D. Cooper and Iyer, {N. N.} and Hoxer, {C. S.} and P. Giangrande",
year = "2017",
doi = "10.1111/hae.13279",
language = "English",
volume = "23",
pages = "821--831",
journal = "Haemophilia",
issn = "1351-8216",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "6",

}

TY - JOUR

T1 - Perioperative management of haemophilia B

T2 - A critical appraisal of the evidence and current practices

AU - Neufeld, E. J.

AU - Solimeno, L.

AU - Quon, D.

AU - Walsh, C.

AU - Seremetis, S.

AU - Cooper, D.

AU - Iyer, N. N.

AU - Hoxer, C. S.

AU - Giangrande, P.

PY - 2017

Y1 - 2017

N2 - Background: While there is substantial literature addressing the principles of general management of haemophilia, literature on perioperative management of haemostasis is scarce. Objective: The aim of this study was to better understand perioperative management among congenital haemophilia B patients (without inhibitors) and to gain insights into real-world surgical practices. Method: A systematic literature review, with an emphasis on haemophilia B, was conducted using EMBASE®, Medline® and the Cochrane Library. Studies from 1974 to June 2015 were accessed, and 132 studies were eligible for the full-study review. An international expert panel with five haematologists and one surgeon reviewed the resulting literature and provided further insights. Results: The literature review revealed that documented experience in the perioperative management of bleeding risk in haemophilia B patients is relatively scarce. Therefore, the review was amended to provide a comprehensive overview of the perioperative management for haemophilia A and B patients; the expert panel applied a particular focus to haemophilia B. Several gaps were identified in the literature including the lack of consensus on defining surgery in terms of bleeding risk, optimal factor levels during surgery and lack of robust evidence on surgical outcomes. The ensuing discussions with the expert panel provided validation of some of the results from the systematic literature review and proposed future directions for perioperative management. Suggestions included collaboration with haemophilia treatment centres (HTCs) to collect real-world data on perioperative management, establishing the need for optimal factor level monitoring practice, and the appropriate adoption of extended half-life products in clinical settings.

AB - Background: While there is substantial literature addressing the principles of general management of haemophilia, literature on perioperative management of haemostasis is scarce. Objective: The aim of this study was to better understand perioperative management among congenital haemophilia B patients (without inhibitors) and to gain insights into real-world surgical practices. Method: A systematic literature review, with an emphasis on haemophilia B, was conducted using EMBASE®, Medline® and the Cochrane Library. Studies from 1974 to June 2015 were accessed, and 132 studies were eligible for the full-study review. An international expert panel with five haematologists and one surgeon reviewed the resulting literature and provided further insights. Results: The literature review revealed that documented experience in the perioperative management of bleeding risk in haemophilia B patients is relatively scarce. Therefore, the review was amended to provide a comprehensive overview of the perioperative management for haemophilia A and B patients; the expert panel applied a particular focus to haemophilia B. Several gaps were identified in the literature including the lack of consensus on defining surgery in terms of bleeding risk, optimal factor levels during surgery and lack of robust evidence on surgical outcomes. The ensuing discussions with the expert panel provided validation of some of the results from the systematic literature review and proposed future directions for perioperative management. Suggestions included collaboration with haemophilia treatment centres (HTCs) to collect real-world data on perioperative management, establishing the need for optimal factor level monitoring practice, and the appropriate adoption of extended half-life products in clinical settings.

KW - Expert panel

KW - Guideline

KW - Haemophilia B

KW - Literature review

KW - Replacement therapy

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=85026311305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026311305&partnerID=8YFLogxK

U2 - 10.1111/hae.13279

DO - 10.1111/hae.13279

M3 - Article

AN - SCOPUS:85026311305

VL - 23

SP - 821

EP - 831

JO - Haemophilia

JF - Haemophilia

SN - 1351-8216

IS - 6

ER -